Elevated plasma endothelial microparticles in alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 34, Issue 3-4, 2012, Pages 174-180

  Xue, Shouru ^a   Cai, Xiuyin ^a   Li, Wanjun ^a   Zhang, Zhengchun ^a   Dong, Wanli ^a   Hui, Guozhen ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cognitive decline; Endothelial microparticles; Flow cytometry

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL DEATH; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANTIGENS, CD31; APOPTOSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; REPUBLIC OF KOREA; SEVERITY OF ILLNESS INDEX;

EID: 84867466546     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000343491     Document Type: Article

References (32)

1. Jellinger KA, Attems J: Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 2005;229-230:37-41.
2. Attems J, Jellinger KA: Capillary cerebral amyloid angiopathy correlates with Alzheimer disease neuropathology. Acta Neuropathol (Berl) 2004;111:1219-1235.
3. Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO: Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 2003;29: 106-117.
4. Hyman BT: New neuropathological criteria for Alzheimer disease. Arch Neurol 1998;55: 1174-1176.
5. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Hermann F, Moulias R: The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging 2002;23:213-219.
6. Alzheimer A: Uber eine eigenartig Erkrankung der Hirnrinde. Allg Z Psychiatrie Psych Ger Med 1907;64:146-148.
7. Nakata-Kudo Y, Mizuno T, Yamada K, Shiga K, Yoshikawa K, Mori S, Nishimura T, Nakajima K, Nakagawa M: Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord 2006; 22:8-14.
8. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM: Dementia after ischaemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996;46:154-159.
9. Rochelle E: Tractenberg, Paul SA. Agreement in cognitive and clinical assessments in Alzheimer's disease. Dement Geriatr Cogn Disord 2009;27:344-352.
10. Boulanger CM, Amabile N, Tedgui A: Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006;48:180-186.
11. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM: Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006;26:2594-2604.
12. Horstman LL, Jy W, Jimenez JJ, Ahn YS: Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9: 1118-1135.
13. Bernal-Mizrachi L, Jy W, Fiero C, et al: Endothelial microparticles correlate with highrisk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004;97:439-446.
14. Preston RA, Jy W, Jimenez JJ, et al: Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41:211-217.
15. Sabatier F, Darmon P, Hugel P, et al: Type 1 and 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002;51:2840-2845.
16. Simak J, Gelderman MP, Yu H, Wright V, Baird AE: Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006;4:1296-1302.
17. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS: Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175-180.
18. Mallat Z, Tedgui A: Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001;88:998-1003.
19. Egashira K: Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J 2002;66:529-533.
20. Xue SR, Xu DH, Yang XX, Dong WL: Alterations in lymphocyte subset patterns and costimulatory molecules in patients with Alzheimer disease. Chinese Med J 2009;122: 1469-1472.
21. Boulanger CM, Scoazec A, Ebrahimian T, et al: Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649-2652.
22. Bernal-Mizrachi L, Jy W, Jimenez JJ, et al: High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003;145:962-970.
23. Williams JB, Jauch EC, Lindsell CJ, Campos B: Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. Acad Emerg Med 2007;14:685-690.
24. Jimenez JJ, Wenche JY, Mauro LM, Horstman LL, Ahn ER, Ahn YS, Minagar A: Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-β1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Multiple Sclerosis 2005;11:310-315.
25. Piccin A, Murphy WG, Smith OP: Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007;21:157-171.
26. Lee ST, Chu K, Jung KH: Reduced circulating angiogenic cells in Alzheimer disease. Neurology 2009;72:1858-1863.
27. Vignini A, Nanetti L, Moroni C: Modifications of platelet from Alzheimer disease patients: a possible relation between membrane properties and NO metabolites. Neurobiol Aging 2007;28:987-994.
28. Aliev G, Palacios HH, Lipsitt AE: Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox Res 2009;16:293-305.
29. Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, Tuder RM, Geraci MW, Voelkel NF: Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 2003; 90:698-703.
30. Boulanger CM, Amabile N, Guerin AP, Pannier B, Leroyer AS, Nguyen C, Mallat Z, Tedgui A, London GM: In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 2008;52:902-908.
31. Amabile N, Heiss C, Real WM, Minasi P, Mc-Glothlin D, Rame EJ, Grossman W, Marco TD, Yeghiazarians Y: Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1268-1275.
32. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H: Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005;45:1622-1630.